• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how exposure to ADHD for a long time could affect a pregnant fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders like impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication must weigh the benefits of taking it against the possible risks for the fetus. Physicians do not have the data needed to make unequivocal recommendations however they can provide information regarding the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a higher risk of fetal malformations, or structural birth defects. Researchers conducted a large sample-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study was not without its flaws. The researchers were unable, in the first place, to separate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the small associations observed among the groups that were exposed to the use of medications or caused by co-morbidities. In addition, the researchers did not examine the long-term outcomes of offspring.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the higher risk of admission was not found to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies can be offset by more beneficial outcomes for both mother and baby of continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if they are able, assist them in developing strategies to improve their coping abilities which can reduce the impact of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. most popular adhd medication (extension.unimagdalena.Edu.co) of the time, these decisions are made in the absence of clear and authoritative evidence regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what the research says on the topic, along with their own judgments for each patient.

Particularly, the issue of potential risks to the baby can be a challenge. The research on this subject is based on observation rather than controlled studies, and the results are in conflict. Furthermore, most studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both information on deceased and live births.

The conclusion The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies have a neutral or slight negative effect. In all cases an in-depth evaluation of the benefits and risks should be conducted.

For women suffering from ADHD and ADD, the decision to discontinue medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. The loss of medication can also affect the ability to safely drive and to perform work-related tasks which are crucial aspects of daily life for those suffering from ADHD.

She recommends women who are uncertain about whether to keep or stop medication in light of their pregnancy, consider educating family members, friends and colleagues on the condition, its impact on daily functioning, and the advantages of continuing the current treatment regimen. It can also aid in ensuring that the woman feels supported as she struggles with her decision. Certain medications can be passed through the placenta. If the patient decides to not take her ADHD medication while breastfeeding, it is crucial to be aware that the medication could be transferred to the infant.

Birth Defects and Risk of

As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing as does the concern about the possible effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. With two massive data sets researchers were able to analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.

The authors of the study did not discover any connection between the use of early medications and other congenital anomalies, like facial deformities or club feet. The results are in the same vein as previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of pregnancy. The risk increased in the latter part of pregnancy when many women began to stop taking their medication.

Women who took ADHD medication in the first trimester of pregnancy were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby that required help breathing at birth. However, the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical issues that could be a contributing factor to these findings.

The researchers hope their study will aid in the clinical decisions of doctors who encounter pregnant women. They recommend that, while discussing the benefits and risks is important however, the decision to stop or continue medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also advise that, while stopping the medication is an alternative, it is not an option that is recommended due to the high incidence of depression and other mental health problems for women who are expecting or post-partum. Further, the research suggests that women who decide to stop their medications are more likely to have a difficult time adapting to life without them following the birth of their baby.

Nursing

It can be a stressful experience to become a mother. Women with ADHD can face severe challenges when they have to manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new adhd medication uk routines. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs are absorbed through breast milk in small quantities, so the risk to the nursing infant is very low. However, the frequency of medication exposure to the infant can differ based on the dosage, frequency it is administered and at what time the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn infant is not well known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the lack of research. This is a difficult decision for the mother, who must weigh the advantages of continuing her medication against the risks to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal time.

A increasing number of studies have shown that women can continue their ADHD medication during pregnancy and while breastfeeding. In response, a rising number of patients are choosing to do so. They have discovered through consultation with their doctor, that the benefits of keeping their current medication far outweigh any possible risks.

Women who suffer from ADHD who are planning to breastfeed should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant people with ADHD understand their symptoms and underlying disorder and learn about treatments and to reinforce existing coping strategies. This should be a multidisciplinary process together with obstetricians, GPs, and psychiatrists. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.